A Randomized, Controlled, Double-blind Clinical Trial of L-arginine as Adjuvant Therapy for Sickle Cell Disease
One of the main problems in sickle cell disease is the decreased bioavailability of nitric oxide and arginine. This study was designed to assess if treating sickle cell disease patients with L-arginine would improve pulmonary arterial pressure and other aspects.
100 Clinical Results associated with Ajinomoto Interamericana Indústria e Comércio Ltda.
0 Patents (Medical) associated with Ajinomoto Interamericana Indústria e Comércio Ltda.
100 Deals associated with Ajinomoto Interamericana Indústria e Comércio Ltda.
100 Translational Medicine associated with Ajinomoto Interamericana Indústria e Comércio Ltda.